Abstract:The cerebrovasculature is essential to brain health and is tasked with ensuring adequate delivery of oxygen and metabolic precursors to ensure normal neurologic function. This is coordinated through a dynamic, multi-directional cellular interplay between vascular, neuronal, and glial cells. Molecular exchanges across the blood–brain barrier or the close matching of regional blood flow with brain activation are not uniformly assigned to arteries, capillaries, and veins. Evidence has supported functional segment… Show more
“…Our morphological and functional understanding of the NVU, through examining the molecular composition and regional specifications of the different cell types in the CNS, has also advanced significantly. This has allowed us to begin to understand the molecular profiles of cellular components of the NVU as well as their specialization and conservation across species ( Cahoy et al, 2008 ; Roesch et al, 2008 ; Zhang et al, 2014 ; Vanlandewijck et al, 2018 ; Ross et al, 2020 ). One aspect of particular interest is to examine glia-to-EC contacts, whether this is impacted by regional specialization, and whether this and NVU function, is influenced by glia/EC identities.…”
Section: Future Directions and Areas Of Scientific Interestmentioning
The neurovascular unit (NVU) is a complex multi-cellular structure consisting of endothelial cells (ECs), neurons, glia, smooth muscle cells (SMCs), and pericytes. Each component is closely linked to each other, establishing a structural and functional unit, regulating central nervous system (CNS) blood flow and energy metabolism as well as forming the blood-brain barrier (BBB) and inner blood-retina barrier (BRB). As the name suggests, the “neuro” and “vascular” components of the NVU are well recognized and neurovascular coupling is the key function of the NVU. However, the NVU consists of multiple cell types and its functionality goes beyond the resulting neurovascular coupling, with cross-component links of signaling, metabolism, and homeostasis. Within the NVU, glia cells have gained increased attention and it is increasingly clear that they fulfill various multi-level functions in the NVU. Glial dysfunctions were shown to precede neuronal and vascular pathologies suggesting central roles for glia in NVU functionality and pathogenesis of disease. In this review, we take a “glio-centric” view on NVU development and function in the retina and brain, how these change in disease, and how advancing experimental techniques will help us address unanswered questions.
“…Our morphological and functional understanding of the NVU, through examining the molecular composition and regional specifications of the different cell types in the CNS, has also advanced significantly. This has allowed us to begin to understand the molecular profiles of cellular components of the NVU as well as their specialization and conservation across species ( Cahoy et al, 2008 ; Roesch et al, 2008 ; Zhang et al, 2014 ; Vanlandewijck et al, 2018 ; Ross et al, 2020 ). One aspect of particular interest is to examine glia-to-EC contacts, whether this is impacted by regional specialization, and whether this and NVU function, is influenced by glia/EC identities.…”
Section: Future Directions and Areas Of Scientific Interestmentioning
The neurovascular unit (NVU) is a complex multi-cellular structure consisting of endothelial cells (ECs), neurons, glia, smooth muscle cells (SMCs), and pericytes. Each component is closely linked to each other, establishing a structural and functional unit, regulating central nervous system (CNS) blood flow and energy metabolism as well as forming the blood-brain barrier (BBB) and inner blood-retina barrier (BRB). As the name suggests, the “neuro” and “vascular” components of the NVU are well recognized and neurovascular coupling is the key function of the NVU. However, the NVU consists of multiple cell types and its functionality goes beyond the resulting neurovascular coupling, with cross-component links of signaling, metabolism, and homeostasis. Within the NVU, glia cells have gained increased attention and it is increasingly clear that they fulfill various multi-level functions in the NVU. Glial dysfunctions were shown to precede neuronal and vascular pathologies suggesting central roles for glia in NVU functionality and pathogenesis of disease. In this review, we take a “glio-centric” view on NVU development and function in the retina and brain, how these change in disease, and how advancing experimental techniques will help us address unanswered questions.
“…Intense research on the vascular landscape of areas like the choroid plexus, where a barrier more permeable than the BBB is critical to CSF production, will surely reveal new functions to the “classical” NVU cells (Liddelow, 2015 ; Lun et al, 2015 ; Kaur et al, 2016 ). These cells making up the NVU, once thought limited to ECs, astrocytes, pericytes and neurons, are also joined by “newcomers,” with perivascular fibroblasts, perivascular macrophages, resident microglia and others now believed to play an active role in cerebrovascular activity (Koizumi et al, 2019 ; Ross et al, 2020 ). With each of these cell types also displaying their own regional heterogeneity across the brain (Masuda et al, 2020 ), it is easy to imagine that even if the cerebrovascular compartment connects into one continuum, it may in fact harbor multiple somewhat distinct regions of specialized cellular composition and function.…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, the development of novel neuroimaging modalities suitable for brain-wide recordings has expanded the toolset required to probe the regional heterogeneity of the NVU that was until recently mostly addressed by single cell RNA sequencing (scRNAseq) and functional magnetic resonance imaging (fMRI). The former is a major contributor in characterizing the single cell transcriptomic profile of the cellular and vascular components of the NVU highlighting region-specific differences at the brain-wide scale (Saunders et al, 2018 ; Ross et al, 2020 ) and beyond what can be achieved with conventional imaging modalities. The latter, fMRI, is a gold standard modality suitable to capture the heterogeneity of hemodynamic responses at the whole brain scale (Devonshire et al, 2012 ) and between white and gray matter (Gawryluk et al, 2014 ).…”
Section: Tools To Study Regional Heterogeneity Of the Nvumentioning
The neurovascular unit (NVU) of the brain is composed of multiple cell types that act synergistically to modify blood flow to locally match the energy demand of neural activity, as well as to maintain the integrity of the blood-brain barrier (BBB). It is becoming increasingly recognized that the functional specialization, as well as the cellular composition of the NVU varies spatially. This heterogeneity is encountered as variations in vascular and perivascular cells along the arteriole-capillary-venule axis, as well as through differences in NVU composition throughout anatomical regions of the brain. Given the wide variations in metabolic demands between brain regions, especially those of gray vs. white matter, the spatial heterogeneity of the NVU is critical to brain function. Here we review recent evidence demonstrating regional specialization of the NVU between brain regions, by focusing on the heterogeneity of its individual cellular components and briefly discussing novel approaches to investigate NVU diversity.
“…It is not clear when fetal endothelial cells gain similar transport properties as the adult ones ( Ek et al, 2012 ). Fully functional endothelial cells are permissive to gases, lipophilic molecules, and a subset of small molecules (<400 Da) ( Ross et al, 2020 ). Additionally, they are capable of carrier-mediated, receptor-mediated, and active transport ( Ross et al, 2020 ).…”
Section: Maternal and Fetal Barriers Protect Fetal Brain From The Effects Of Environmental Adversitiesmentioning
Over the past decades, a growing body of evidence has demonstrated the impact of prenatal environmental adversity on the development of the human embryonic and fetal brain. Prenatal environmental adversity includes infectious agents, medication, and substances of use as well as inherently maternal factors, such as diabetes and stress. These adversities may cause long-lasting effects if occurring in sensitive time windows and, therefore, have high clinical relevance. However, our knowledge of their influence on specific cellular and molecular processes of in utero brain development remains scarce. This gap of knowledge can be partially explained by the restricted experimental access to the human embryonic and fetal brain and limited recapitulation of human-specific neurodevelopmental events in model organisms. In the past years, novel 3D human stem cell-based in vitro modeling systems, so-called brain organoids, have proven their applicability for modeling early events of human brain development in health and disease. Since their emergence, brain organoids have been successfully employed to study molecular mechanisms of Zika and Herpes simplex virus-associated microcephaly, as well as more subtle events happening upon maternal alcohol and nicotine consumption. These studies converge on pathological mechanisms targeting neural stem cells. In this review, we discuss how brain organoids have recently revealed commonalities and differences in the effects of environmental adversities on human neurogenesis. We highlight both the breakthroughs in understanding the molecular consequences of environmental exposures achieved using organoids as well as the on-going challenges in the field related to variability in protocols and a lack of benchmarking, which make cross-study comparisons difficult.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.